Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
about
The current role of thiazolidinediones in diabetes management.Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Sitagliptin and oral cancer risk in type 2 diabetes patients.
P2860
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@ast
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@en
type
label
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@ast
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@en
prefLabel
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@ast
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@en
P2860
P1433
P1476
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
@en
P2093
Chin-Hsiao Tseng
P2860
P2888
P356
10.1186/S12885-015-1057-8
P407
P577
2015-02-06T00:00:00Z
P5875
P6179
1007953469